Extracellular Vesicles in Renal Diseases: More than Novel Biomarkers?

Journal of the American Society of Nephrology

Volumn 27, Issue 1, 2016, Pages 12-26

  Erdbrügger, Uta ^a   Le, Thu H ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; FETUIN A; GELATINASE; MICROSOMAL AMINOPEPTIDASE; PODOCALYXIN; PODOPLANIN; SODIUM POTASSIUM CHLORIDE COTRANSPORTER 2; SODIUM PROTON EXCHANGE PROTEIN;

ACUTE KIDNEY FAILURE; BLOOD VESSEL INJURY; CELL COMPOSITION; CELL MEMBRANE; CHRONIC KIDNEY FAILURE; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; END STAGE RENAL DISEASE; EXOSOME; GLOMERULOPATHY; HUMAN; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; MOLECULAR BIOLOGY; MULTIVESICULAR BODY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TUBULAR DYSFUNCTION; UREMIA; URINE; ACUTE KIDNEY INJURY; BLOOD; GLOMERULUS; KIDNEY DISEASES;

ACUTE KIDNEY INJURY; BIOMARKERS; EXTRACELLULAR VESICLES; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS;

EID: 84954425157     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015010074     Document Type: Review

References (139)

1. Burger D, Schock S, Thompson CS, Montezano AC, Hakim AM, Touyz RM: Microparticles: Biomarkers and beyond. Clin Sci (Lond) 124: 423-441, 2013
2. Barteneva NS, Fasler-Kan E, Bernimoulin M, Stern JN, Ponomarev ED, Duckett L, Vorobjev IA: Circulating microparticles: Square the circle. BMC Cell Biol 14: 23, 2013
3. Dear JW, Street JM, Bailey MA: Urinary exosomes: A reservoir for biomarker discovery and potential mediators of intrarenal signalling. Proteomics 13: 1572-1580, 2013
4. Salih M, Zietse R, Hoorn EJ: Urinary extracellular vesicles and the kidney: Biomarkers and beyond. Am J Physiol Renal Physiol 306: F1251-F1259, 2014
5. Wolf P: The nature and significance of platelet products in human plasma. Br J Haematol 13: 269-288, 1967
6. Xiao X, Ma X, Liu L, Wang J, Bi K, Liu Y, Fan R, Zhao B, Chen Y, Chen J: Cellular membrane microparticles: Potential targets of combinational therapy for vascular disease [published online ahead of print October 14, 2014]. Curr Vasc Pharmaco
7. Kourembanas S: Exosomes: Vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. Annu Rev Physiol 77: 13-27, 2015
8. EL Andaloussi S, Mäger I, Breakefield XO, Wood MJ: Extracellular vesicles: Biology and emerging therapeutic opportunities. Nat Rev Drug Discov 12: 347-357, 2013
9. van der Pol E, Böing AN, Harrison P, Sturk A, Nieuwland R: Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev 64: 676-705, 2012
10. Colombo M, Raposo G, Théry C: Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular
11. Burger D, Schock S, Thompson CS, Montezano AC, Hakim AM, Touyz RM: Microparticles: Biomarkers and beyond. Clin Sci (Lond) 124: 423-441, 2013
12. Barteneva NS, Fasler-Kan E, Bernimoulin M, Stern JN, Ponomarev ED, Duckett L, Vorobjev IA: Circulating microparticles: Square the circle. BMC Cell Biol 14: 23, 2013
13. Dear JW, Street JM, Bailey MA: Urinary exosomes: A reservoir for biomarker discovery and potential mediators of intrarenal signalling. Proteomics 13: 1572-1580, 2013
14. Salih M, Zietse R, Hoorn EJ: Urinary extracellular vesicles and the kidney: Biomarkers and beyond. Am J Physiol Renal Physiol 306: F1251-F1259, 2014
15. Wolf P: The nature and significance of platelet products in human plasma. Br J Haematol 13: 269-288, 1967
16. Xiao X, Ma X, Liu L, Wang J, Bi K, Liu Y, Fan R, Zhao B, Chen Y, Chen J: Cellular membrane microparticles: Potential targets of combinational therapy for vascular disease [published online ahead of print October 14, 2014]. Curr Vasc Pharmaco
17. Kourembanas S: Exosomes: Vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. Annu Rev Physiol 77: 13-27, 2015
18. EL Andaloussi S, Mäger I, Breakefield XO, Wood MJ: Extracellular vesicles: Biology and emerging therapeutic opportunities. Nat Rev Drug Discov 12: 347-357, 2013
19. van der Pol E, Böing AN, Harrison P, Sturk A, Nieuwland R: Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev 64: 676-705, 2012
20. Colombo M, Raposo G, Théry C: Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular Figure 5. Origin of EVs in renal diseases. Proteomic analysis has identified uEVs, including exosomes from glomerular, tubular, prostate, and bladder cells.13,27 Here, we show a schematic drawing of the glomerulus and kidney tubule. Several markers of podocyte damage have been identified in uEVs, including podocalyxin, podoplanin,83 and WT-1.80,81 A protective role of EVs derived from MSCs has been described in models of kidney damage. It is suggested that these EVs fromMSCs are involved in transfer of mRNA, miRNA, and proteins and reprogramming of their phenotypes.62 Solute and water transporters have been identified on uEVs: Sodium potassium chloride cotransporter (NaKCl) from the thick ascending limb,27 sodium chloride cotransporter (NCC) from the distal tubule, 89 and AQP-2 deriving from the collecting duct.43 Figure adapted from previous publications.3,4,44 22 Journal of the American Society of Nephrology J Am Soc Nephrol 27: 12-26, 2016 BRIEF REVIEW www.jasn.org vesicles. Annu Rev Cell Dev Biol 30: 255-289, 2014
21. Gould SJ, Raposo G: As we wait: Coping with an imperfect nomenclature for extracellular vesicles. J Extracell Vesicles 2: 10.3402/jev.v2i0.20389, 2013
22. Lötvall J, Hill AF, Hochberg F, Buzás EI, Di Vizio D, Gardiner C, Gho YS, Kurochkin IV, Mathivanan S, Quesenberry P, Sahoo S, Tahara H, Wauben MH, Witwer KW, Théry C: Minimal experimental requirements for definition of extracellular vesicles and their functions: A position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles 3: 26913, 2014
23. Pisitkun T, Shen RF, Knepper MA: Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 101: 13368-13373, 2004
24. Hiemstra TF, Charles PD, Gracia T, Hester SS, Gatto L, Al-Lamki R, Floto RA, Su Y, Skepper JN, Lilley KS, Karet Frankl FE: Human urinary exosomes as innate immune effectors. J Am Soc Nephrol 25: 2017-2027, 2014
25. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, Morando L, Busca A, Falda M, Bussolati B, Tetta C, Camussi G: Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20: 1053-1067, 2009
26. Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJ, Hole P, Carr B, Redman CW, Harris AL, Dobson PJ, Harrison P, Sargent IL: Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine (Lond) 7: 780-788, 2011
27. van der Pol E, Coumans FA, Grootemaat AE, Gardiner C, Sargent IL, Harrison P, Sturk A, van Leeuwen TG, Nieuwland R: Particle size distribution of exosomes and microvesicles determined by transmission electronmicroscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing. J Thromb Haemost 12: 1182-1192, 2014
28. Chandler WL, Yeung W, Tait JF: A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer. J Thromb Haemost 9: 1216-1224, 2011
29. Robert S, Poncelet P, Lacroix R, Raoult D, Dignat-George F: More on: Calibration for the measurement of microparticles: Value of calibrated polystyrene beads for flow cytometry-based sizing of biological microparticles. J Thromb Haemost 9: 1676-1678, 2011
30. van der Pol E, van Gemert MJ, Sturk A, Nieuwland R, van Leeuwen TG: Single vs. swarm detection of microparticles and exosomesby flowcytometry.JThrombHaemost 10: 919-930, 2012
31. Maas SL, de Vrij J, van der Vlist EJ, Geragousian B, van Bloois L,Mastrobattista E, Schiffelers RM, Wauben MH, Broekman ML, Nolte-'t Hoen EN: Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics. J Control Release 200: 87-96, 2015
32. Zhou H, Cheruvanky A, Hu X, Matsumoto T, Hiramatsu N, Cho ME, Berger A, Leelahavanichkul A, Doi K, Chawla LS, Illei GG, Kopp JB, Balow JE, Austin HA 3rd, Yuen PS, Star RA: Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int 74: 613-621, 2008
33. Miranda KC, Bond DT, Levin JZ, Adiconis X, Sivachenko A, Russ C, Brown D, Nusbaum C, Russo LM: Massively parallel sequencing of human urinary exosome/microvesicle RNA reveals a predominance of non-coding RNA. PLoS One 9: E96094, 2014
34. Cheng L, Sun X, Scicluna BJ, Coleman BM, Hill AF: Characterization and deep sequencing analysis of exosomal and nonexosomalmiRNA in human urine. Kidney Int 86: 433-444, 2014
35. Miranda KC, Bond DT, McKee M, Skog J, P?unescu TG, Da Silva N, Brown D, Russo LM: Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int 78: 191-199, 2010
36. Mathivanan S, Ji H, Simpson RJ: Exosomes: Extracellularorganelles important in intercellular communication. J Proteomics 73: 1907-1920, 2010
37. Gonzales PA, Pisitkun T, Hoffert JD, Tchapyjnikov D, Star RA, Kleta R, Wang NS, Knepper MA: Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol 20: 363-379, 2009
38. PiccinA,MurphyWG, SmithOP: Circulating microparticles: Pathophysiology and clinical implications. Blood Rev 21: 157-171, 2007
39. Morel O, Jesel L, Freyssinet JM, Toti F: Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 31: 15-26, 2011
40. Dey-Hazra E, Hertel B, Kirsch T,Woywodt A, Lovric S, Haller H, Haubitz M, Erdbruegger U: Detection of circulating microparticles by flow cytometry: Influence of centrifugation, filtration of buffer, and freezing. VascHealth Risk Manag 6: 1125-1133, 2010
41. Arraud N, Linares R, Tan S, Gounou C, Pasquet JM, Mornet S, Brisson AR: Extracellular vesicles from blood plasma: Determination of theirmorphology, size, phenotype and concentration. J Thromb Haemost 12: 614-627, 2014
42. Hara M, Yanagihara T, Hirayama Y, Ogasawara S, Kurosawa H, Sekine S, Kihara I: Podocyte membrane vesicles in urine originate from tip vesiculation of podocyte microvilli. Hum Pathol 41: 1265-1275, 2010
43. van der Pol E, Hoekstra AG, Sturk A, Otto C, van Leeuwen TG, Nieuwland R: Optical and non-optical methods for detection and characterization of microparticles and exosomes. J ThrombHaemost 8: 2596-2607, 2010
44. van der Pol E, Coumans F, Varga Z, Krumrey M, Nieuwland R: Innovation in detection of microparticles and exosomes. J Thromb Haemost 11[Suppl 1]: 36-45, 2013
45. Shet AS: Characterizing blood microparticles: Technical aspects and challenges. Vasc Health Risk Manag 4: 769-774, 2008
46. Yuana Y, Bertina RM, Osanto S: Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost 105: 396-408, 2011
47. Jayachandran M, Miller VM, Heit JA, Owen WG: Methodology for isolation, identification and characterization of microvesicles in peripheral blood. J Immunol Methods 375: 207-214, 2012
48. Trummer A, De Rop C, Tiede A, Ganser A, Eisert R: Recovery and composition of microparticles after snap-freezing depends on thawing temperature. Blood Coagul Fibrinolysis 20: 52-56, 2009
49. Witwer KW, Buzas EI, Bemis LT, Bora A, Lasser C, Lotvall J, Nolte-'t Hoen EN, Piper MG, Sivaraman S, Skog J, Thery C,Wauben MH,Hochberg F: Standardization of sample collection, isolation and analysismethods in extracellular vesicle research. J Extracell Vesicles 2: 10.3402/jev.v2i0.20360, 2013
50. Lacroix R, Judicone C, Mooberry M, Boucekine M, Key NS, Dignat-George F; The ISTH SSC Workshop: Standardization of pre-analytical variables in plasma microparticle determination: Results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop [published online ahead of print April 2, 2013]. J Thromb Haemost 10.1111/jth.12207
51. Fernández-Llama P, Khositseth S, Gonzales PA, Star RA, Pisitkun T, KnepperMA: Tamm-Horsfall protein and urinary exosome isolation. Kidney Int 77: 736-742, 2010
52. Rood IM, Deegens JK, Merchant ML, TamboerWP,Wilkey DW,Wetzels JF, Klein JB: Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome. Kidney Int 78: 810-816, 2010
53. Kanno K, Sasaki S, Hirata Y, Ishikawa S, Fushimi K, Nakanishi S, Bichet DG,Marumo F: Urinary excretion of aquaporin-2 in patients with diabetes insipidus.NEngl JMed 332: 1540-1545, 1995
54. Musante L, Tataruch DE, Holthofer H: Use and isolation of urinary exosomes as biomarkers for diabetic nephropathy. Front Endocrinol (Lausanne) 5: 149, 2014
55. Oosthuyzen W, Sime NE, Ivy JR, Turtle EJ, Street JM, Pound J, Bath LE, Webb DJ, Gregory CD, Bailey MA, Dear JW: Quantification of human urinary exosomes by nanoparticle tracking analysis. J Physiol 591: 5833-5842, 2013
56. Filipe V, Hawe A, Jiskoot W: Critical evaluation of Nanoparticle Tracking Analysis (NTA) byNanoSight for the measurement of nanoparticles and protein aggregates. Pharm Res 27: 796-810, 2010
57. Vogel R, Willmott G, Kozak D, Roberts GS, Anderson W, Groenewegen L, Glossop B, Barnett A, Turner A, Trau M: Quantitative sizing of nano/microparticles with a tunable elastomeric pore sensor. Anal Chem 83: 3499-3506, 2011
58. Coulter WH: Means for counting particles suspended in a fluid. US Patent 2,656,508. 1953
59. Dignat-Goerge F: Questionnaire on Microparticle Detection and Characterization: A Retrospective Analysis. Vascular Biology Working Group. Standardization Sub Committee International Society of Thrombosis and Hemostasis; 2005, Sydney, Australia. Vascular Biology Working Group, Sydney, Australia, Standatization Sub Committee International Society of Thrombosis and Hemostasis, 2005
60. Robert S, Lacroix R, Poncelet P, Harhouri K, Bouriche T, Judicone C, Wischhusen J, Arnaud L, Dignat-George F: High-sensitivity flow cytometry provides access to standardized measurement of small-sizemicroparticles-brief report. Arterioscler Thromb Vasc Biol 32: 1054-1058, 2012
61. Kormelink TG, Arkesteijn GJ, Nauwelaers FA, van den Engh G, Nolte-'t Hoen EN, Wauben MH: Prerequisites for the analysis and sorting of extracellular vesicle subpopulations by high-resolution flow cytometry [published online ahead of print February 16, 2015]. Cytometry A 10.1002/cyto.a.22644
62. Arraud N, Gounou C, Turpin D, Brisson AR: Fluorescence triggering: A general strategy for enumerating and phenotyping extracellular vesicles by flow cytometry [published online ahead of print April 9, 2015]. Cytometry A 10.1002/cyto.a.22669
63. Erdbrügger U, Rudy CK, E Etter M, Dryden KA, Yeager M, Klibanov AL, Lannigan J: Imaging flow cytometry elucidates limitations of microparticle analysis by conventional flow cytometry. Cytometry A 85: 756-770, 2014
64. Headland SE, Jones HR, D'Sa AS, Perretti M, Norling LV: Cutting-edge analysis of extracellular microparticles using Image-Stream(X) imaging flow cytometry. Sci Rep 4: 5237, 2014
65. Osumi K, Ozeki Y, Saito S, Nagamura Y, Ito H, Kimura Y, Ogura H, Nomura S: Development and assessment of enzyme immunoassay for platelet-derived microparticles. Thromb Haemost 85: 326-330, 2001
66. Yuana Y, Koning RI, Kuil ME, Rensen PC, Koster AJ, Bertina RM, Osanto S: Cryoelectron microscopy of extracellular vesicles in fresh plasma. J Extracell Vesicles 2: 10.3402/jev.v2i0.21494, 2013
67. du Cheyron D, Daubin C, Poggioli J, Ramakers M, Houillier P, Charbonneau P, Paillard M: Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. Am J Kidney Dis 42: 497-506, 2003
68. Zhou H, Pisitkun T, Aponte A, Yuen PS, Hoffert JD, Yasuda H, Hu X, Chawla L, Shen RF, Knepper MA, Star RA: Exosomal Fetuin-A identified by proteomics: A novel urinary biomarker for detecting acute kidney injury. Kidney Int 70: 1847-1857, 2006
69. Alvarez S, Suazo C, Boltansky A, Ursu M, Carvajal D, Innocenti G, Vukusich A, Hurtado M, Villanueva S, Carreño JE, Rogelio A, Irarrazabal CE: Urinary exosomes as a source of kidney dysfunction biomarker in renal transplantation. Transplant Proc 45: 3719-3723, 2013
70. Bianchi F, Sala E, Donadei C, Capelli I, La Manna G: Potential advantages of acute kidney injury management by mesenchymal stem cells. World J Stem Cells 6: 644-650, 2014
71. Erpicum P, Detry O, Weekers L, Bonvoisin C, Lechanteur C, Briquet A, Beguin Y, Krzesinski JM, Jouret F: Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion. Nephrol Dial Transplant 29: 1487-1493, 2014
72. Camussi G, Deregibus MC, Tetta C: Paracrine/endocrine mechanism of stem cells on kidney repair: Role of microvesicle-mediated transfer of genetic information. Curr Opin Nephrol Hypertens 19: 7-12, 2010
73. Bruno S, Grange C, Collino F, Deregibus MC, Cantaluppi V, Biancone L, Tetta C, Camussi G: Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS One 7: E33115, 2012
74. Reis LA, Borges FT, Simões MJ, Borges AA, Sinigaglia-Coimbra R, Schor N: Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicininduced acute kidney injury through paracrine effects in rats. PLoS One 7: E44092, 2012
75. Cantaluppi V, Gatti S,Medica D, Figliolini F, Bruno S, Deregibus MC, Sordi A, Biancone L, Tetta C, Camussi G: Microvesicles derived from endothelial progenitor cells protect the kidney fromischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int 82: 412-427, 2012
76. Collino F, Bruno S, Incarnato D, Dettori D, Neri F, Provero P, Pomatto M, Oliviero S, Tetta C, Quesenberry PJ, Camussi G: AKI recovery induced by mesenchymal stromal cell-derived extracellular vesicles carrying MicroRNAs [published online ahead of print April 21, 2015]. J Am Soc Nephrol doi: ASN.2014070710
77. Amabile N, Guérin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J, LondonGM, Tedgui A, Boulanger CM: Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 16: 3381-3388, 2005
78. AmabileN,Guérin AP, Tedgui A, Boulanger CM, London GM: Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: A pilot study. Nephrol Dial Transplant 27: 1873-1880, 2012
79. Chen YL, Chen CH, Wallace CG, Wang HT, Yang CC, Yip HK: Levels of circulating microparticles in patients with chronic cardiorenal disease. J Atheroscler Thromb 22: 247-256, 2015
80. Soriano S, CarmonaA, Triviño F, Rodriguez M, Alvarez-Benito M,Martín-MaloA,Alvarez-Lara MA, Ramírez R, Aljama P, Carracedo J: Endothelial damage and vascular calcification in patients with chronic kidney disease. Am J Physiol Renal Physiol 307: F1302-F1311, 2014
81. Buendía P,Montes de Oca A, Madueño JA, Merino A,Martín-Malo A, Aljama P, Ramírez R, Rodríguez M, Carracedo J: Endothelial microparticles mediate inflammationinduced vascular calcification. FASEB J 29: 173-181, 2015
82. Farag YM, Keithy-Reddy SR, Mittal BV, Bansal V, Fareed J, Singh AK: Modulation of platelet activation in chronic kidney disease patients on erythropoiesis-stimulating agents. Clin Appl Thromb Hemost 18: 453-461, 2012
83. Daniel L, Fakhouri F, Joly D, Mouthon L, NusbaumP,Grunfeld JP, Schifferli J, Guillevin L, Lesavre P, Halbwachs-Mecarelli L: Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int 69: 1416-1423, 2006
84. Gao C, Xie R, Yu C, Wang Q, Shi F, Yao C, Xie R, Zhou J, Gilbert GE, Shi J: Procoagulant activity of erythrocytes and platelets through phosphatidylserine exposure and microparticles release in patients with nephrotic syndrome. Thromb Haemost 107: 681-689, 2012
85. Merino A, Portolés J, Selgas R, Ojeda R, Buendia P, Ocaña J, Bajo MA, del Peso G, Carracedo J, Ramírez R, Martín-Malo A, Aljama P: Effect of different dialysis modalities on microinflammatory status and endothelial damage. Clin J AmSocNephrol 5: 227-234, 2010
86. Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, Brunet P, Dignat-George F: Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 4: 566-573, 2006
87. Dursun I, Poyrazoglu HM, Gunduz Z, Ulger H, Yykylmaz A, Dusunsel R, Patyroglu T, Gurgoze M: The relationship between circulating endothelial microparticles and arterial stiffness and atherosclerosis in children with chronic kidney disease. Nephrol Dial Transplant 24: 2511-2518, 2009
88. Meijers BK, Van Kerckhoven S, Verbeke K, Dehaen W, Vanrenterghem Y, Hoylaerts MF, Evenepoel P: The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 54: 891-901, 2009
89. Weber C, Sigrist M, Romann A, Whalen BA, Levin A: Exploring the relationships between hemoglobin, the endothelium and vascular health in patients with chronic kidney disease. Nephron Extra 1: 190-200, 2011
90. Zhou H, Kajiyama H, Tsuji T, Hu X, Leelahavanichkul A, Vento S, Frank R, Kopp JB, Trachtman H, Star RA, Yuen PS: Urinary exosomal Wilms' tumor-1 as a potential biomarker for podocyte injury. Am J Physiol Renal Physiol 305: F553-F559, 2013
91. Lee H, Han KH, Lee SE, Kim SH, Kang HG, Cheong HI: Urinary exosomal WT1 in childhood nephrotic syndrome. Pediatr Nephrol 27: 317-320, 2012
92. Ramani P, Cowell JK: The expression pattern of Wilms' tumour gene (WT1) product in normal tissues and paediatric renal tumours. J Pathol 179: 162-168, 1996
93. BurgerD,Thibodeau JF,HoltermanCE,Burns KD, Touyz RM, Kennedy CR: Urinary podocyte microparticles identify prealbuminuric diabetic glomerular injury. J AmSocNephrol 25: 1401-1407, 2014
94. Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC: Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. Proteomics 11: 2459-2475, 2011
95. Kalani A, Mohan A, Godbole MM, Bhatia E, Gupta A, Sharma RK, Tiwari S: Wilm's tumor-1 protein levels in urinary exosomes from diabetic patients with or without proteinuria. PLoS One 8: E60177, 2013
96. Barutta F, Tricarico M, Corbelli A, Annaratone L, Pinach S, Grimaldi S, Bruno G, Cimino D, Taverna D, Deregibus MC, Rastaldi MP, Perin PC, Gruden G: Urinary exosomal microRNAs in incipient diabetic nephropathy. PLoS One 8: E73798, 2013
97. Hoorn EJ, Pisitkun T, Zietse R, Gross P, Frokiaer J,Wang NS, Gonzales PA, Star RA, Knepper MA: Prospects for urinary proteomics: Exosomes as a source of urinary biomarkers. Nephrology (Carlton) 10: 283-290, 2005
98. Street JM, Birkhoff W, Menzies RI, Webb DJ, Bailey MA, Dear JW: Exosomal transmission of functional aquaporin 2 in kidney cortical collecting duct cells. J Physiol 589: 6119-6127, 2011
99. Joo KW, Lee JW, Jang HR, Heo NJ, Jeon US, Oh YK, Lim CS, Na KY, Kim J, Cheong HI, Han JS: Reduced urinary excretion of thiazide-sensitive Na-Cl cotransporter in Gitelman syndrome: Preliminary data. Am J Kidney Dis 50: 765-773, 2007
100. Yoder BK, Hou X, Guay-Woodford LM: The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J Am Soc Nephrol 13: 2508-2516, 2002
101. Gerlach JQ, Krüger A, Gallogly S, Hanley SA, Hogan MC, Ward CJ, Joshi L, Griffin MD: Surface glycosylation profiles of urine extracellular vesicles. PLoS One 8: E74801, 2013
102. Hogan MC, Bakeberg JL, Gainullin VG, Irazabal MV, Harmon AJ, Lieske JC, Charlesworth MC, Johnson KL, Madden BJ, Zenka RM, McCormick DJ, Sundsbak JL, Heyer CM, Torres VE, Harris PC, Ward CJ: Identification of biomarkers for PKD1 using urinary exosomes [published online ahead of print December 4, 2014]. J Am Soc Nephrol doi:ASN.2014040354
103. Sonoda H, Yokota-Iked N, Oshikawa S, Kanno Y, Yoshinaga K, Uchida K, Ueda Y, Kimiya K, Uezono S, Ueda A, Ito K, Ikeda M: Decreased abundance of urinary exosomal aquaporin-1 in renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 297: F1006-F1016, 2009
104. T?kés-FüzesiM, Woth G, Ernyey B, Vermes I, Mühl D, Bogár L, Kovács GL: Microparticles and acute renal dysfunction in septic patients. J CritCare 28(2): 141-147, 2013
105. Zhou Y, Xu H, XuW,Wang B, Wu H, Tao Y, Zhang B, Wang M, Mao F, Yan Y, Gao S, Gu H, Zhu W, Qian H: Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Res Ther 4: 34, 2013
106. Tomasoni S, Longaretti L, Rota C, Morigi M, Conti S,Gotti E,CapelliC, IntronaM,Remuzzi G, Benigni A: Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev 22: 772-780, 2013
107. Choi HY, Moon SJ, Ratliff BB, Ahn SH, Jung A, LeeM, Lee S, LimBJ, KimBS, PlotkinMD, Ha SK, Park HC: Microparticles fromkidneyderived mesenchymal stem cells act as carriers of proangiogenic signals and contribute to recovery from acute kidney injury. PLoS One 9: E87853, 2014
108. Ando M, Iwata A, Ozeki Y, Tsuchiya K, Akiba T, Nihei H: Circulating plateletderived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients. Kidney Int 62: 1757-1763, 2002
109. Boulanger CM, Amabile N, Guérin AP, Pannier B, Leroyer AS,Mallat CN, Tedgui A, London GM: In vivo shear stress determines circulating levels of endothelialmicroparticles in end-stage renal disease. Hypertension 49: 902-908, 2007
110. Trappenburg MC, van Schilfgaarde M, Frerichs FC, Spronk HM, ten Cate H, de Fijter CW, Terpstra WE, Leyte A: Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle numbers with reduced procoagulant capacity. Nephrol Dial Transplant 27: 1446-1453, 2012
111. Sakurai K, Saito T, Yamauchi F, Asahi D, Hosoya H: Comparison of the effects of predilution and postdilution hemodiafiltration on neutrophils, lymphocytes and platelets. J ArtifOrgans 16: 316-321, 2013
112. Di Marco GS, König M, Stock C, Wiesinger A, Hillebrand U, Reiermann S, Reuter S, Amler S, Köhler G, Buck F, Fobker M, Kümpers P, Oberleithner H, Hausberg M, Lang D, Pavenstädt H, Brand M: High phosphate directly affects endothelial function by downregulating annexin II. Kidney Int 83: 213-222, 2013
113. van Koppen A, Joles JA, van Balkom BW, Lim SK, de Kleijn D, Giles RH, Verhaar MC: Human embryonic mesenchymal stem cellderived conditioned medium rescues kidney function in rats with established chronic kidney disease. PLoS One 7: E38746, 2012
114. Sun AL, Deng JT, Guan GJ, Chen SH, Liu YT, Cheng J, Li ZW, Zhuang XH, Sun FD, Deng HP: Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease. Diab Vasc Dis Res 9: 301-308, 2012
115. Zubiri I, Posada-Ayala M, Sanz-Maroto A, Calvo E,Martin-LorenzoM, Gonzalez-Calero L, de la Cuesta F, Lopez JA, Fernandez-Fernandez B, Ortiz A, Vivanco F, Alvarez-Llamas G: Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis. J Proteomics 96: 92-102, 2014
116. Hara M, Yanagihara T, Kihara I, Higashi K, Fujimoto K, Kajita T: Apical cell membranes are shed into urine from injured podocytes: A novel phenomenon of podocyte injury. J Am Soc Nephrol 16: 408-416, 2005
117. Tkaczyk M, Baj Z: Surface markers of platelet function in idiopathic nephrotic syndrome in children. Pediatr Nephrol 17: 673-677, 2002
118. Brogan PA, Shah V, Brachet C, Harnden A, Mant D, Klein N, DillonMJ: Endothelial and platelet microparticles in vasculitis of the young. Arthritis Rheum 50: 927-936, 2004
119. Erdbruegger U, Grossheim M, Hertel B, Wyss K, Kirsch T, Woywodt A, Haller H, Haubitz M: Diagnostic role of endothelial microparticles in vasculitis. Rheumatology (Oxford) 47: 1820-1825, 2008
120. Kümpers P, Erdbrügger U, Grossheim M, Meyer GP, Hiss M, Gwinner W, Haller H, Haubitz M: Endothelial microparticles as a diagnostic aid in Churg-Strauss vasculitis-induced cardiomyopathy. Clin Exp Rheumatol 26[Suppl 49]: S86-S89, 2008
121. Eleftheriou D, Hong Y, Klein NJ, Brogan PA: Thromboembolic disease in systemic vasculitis is associated with enhanced microparticle-mediated thrombin generation. J Thromb Haemost 9: 1864-1867, 2011
122. Hong Y, Eleftheriou D, Hussain AA, Price-Kuehne FE, Savage CO, Jayne D, LittleMA, Salama AD, Klein NJ, Brogan PA: Antineutrophil cytoplasmic antibodies stimulate release of neutrophil microparticles. J Am Soc Nephrol 23: 49-62, 2012
123. Yahata T, Suzuki C, Yoshioka A, Hamaoka A, Ikeda K: Platelet activation dynamics evaluated using platelet-derived microparticles in Kawasaki disease. Circ J 78: 188-193, 2014
124. Ding YY, Ren Y, Feng X, Xu QQ, Sun L, Zhang JM, Dou JJ, Lv HT, Yan WH: Correlation between brachial artery flow-mediated dilation and endothelial microparticle levels for identifying endothelial dysfunction in children with Kawasaki disease. Pediatr Res 75: 453-458, 2014
125. Pitanga TN, de Aragao Franca L, Rocha VC, Meirelles T, Borges VM, Goncalves MS, Pontes-de-Carvalho LC, Noronha-Dutra AA, dos-Santos WL: Neutrophil-derived microparticles induce myeloperoxidasemediated damage of vascular endothelial cells. BMC Cell Biol 15: 21, 2014
126. Jimenez JJ, Jy W, Mauro LM, Horstman LL, Ahn YS: Elevated endothelialmicroparticles in thrombotic thrombocytopenic purpura: Findings frombrain and renalmicrovascular cell culture and patients with active disease. Br J Haematol 112: 81-90, 2001
127. Camus SM, Gausserès B, Bonnin P, Loufrani L, Grimaud L, Charue D, De Moraes JA, Renard JM, Tedgui A, Boulanger CM, Tharaux PL, Blanc-Brude OP: Erythrocyte microparticles can induce kidney vasoocclusions in a murine model of sickle cell disease. Blood 120: 5050-5058, 2012
128. Isobe K, Mori T, Asano T, Kawaguchi H, Nonoyama S, Kumagai N, Kamada F, Morimoto T, Hayashi M, Sohara E, Rai T, Sasaki S, Uchida S: Development of enzymelinked immunosorbent assays for urinary thiazide-sensitive Na-Cl cotransporter measurement. Am J Physiol Renal Physiol 305: F1374-F1381, 2013
129. van der LubbeN, Jansen PM, SalihM, Fenton RA, van denMeirackerAH,DanserAH, Zietse R, Hoorn EJ. The phosphorylated sodium chloride cotransporter in urinary exosomes is superior to prostasin as a marker for aldosteronism. Hypertension 60: 741-748, 2012
130. Hogan MC, Manganelli L, Woollard JR, Masyuk AI,Masyuk TV,Tammachote R,Huang BQ, Leontovich AA, Beito TG, Madden BJ, Charlesworth MC, Torres VE, LaRusso NF, Harris PC, Ward CJ: Characterization of PKD protein-positive exosome-like vesicles. J Am Soc Nephrol 20: 278-288, 2009
131. Al-Massarani G, Vacher-Coponat H, Paul P, Widemann A, Arnaud L, Loundou A, Robert S, Berland Y, Dignat-George F, Camoin-Jau L: Impact of immunosuppressive treatment on endothelial biomarkers after kidney transplantation. Am J Transplant 8: 2360-2367, 2008
132. Al-Massarani G, Vacher-Coponat H, Paul P, Arnaud L, Loundou A, Robert S, Moal V, Berland Y, Dignat-George F, Camoin-Jau L: Kidney transplantationdecreases the level and procoagulant activity of circulating microparticles. Am J Transplant 9: 550-557, 2009
133. Pisitkun T, Gandolfo MT, Das S, Knepper MA, Bagnasco SM: Application of systems biology principles to protein biomarker discovery: Urinary exosomal proteome in renal transplantation. Proteomics Clin Appl 6: 268-278, 2012
134. Peake PW, Pianta TJ, Succar L, Fernando M, Pugh DJ, McNamara K, Endre ZH: A comparison of the ability of levels of urinary biomarker proteins and exosomal mRNA to predict outcomes after renal transplantation. PLoS One 9: E98644, 2014
135. Esteva-Font C, Guillén-Gómez E, Diaz JM, Guirado L, Facundo C, Ars E, Ballarin JA, Fernández-Llama P: Renal sodium transporters are increased in urinary exosomes of cyclosporine-treated kidney transplant patients. Am J Nephrol 39: 528-535, 2014
136. Chatelet F, Brianti E, Ronco P, Roland J, Verroust P: Ultrastructural localization by monoclonal antibodies of brush border antigens expressed by glomeruli. I. Renal distribution. Am J Pathol 122: 500-511, 1986
137. Lacroix R, Robert S, Poncelet P, Dignat-George F: Overcoming limitations of microparticle measurement by flow cytometry. Semin Thromb Hemost 36: 807-818, 2010
138. Yuana Y, Oosterkamp TH, Bahatyrova S, Ashcroft B, Garcia Rodriguez P, Bertina RM, Osanto S: Atomic force microscopy: A novel approach to the detection of nanosized bloodmicroparticles. J Thromb Haemost 8: 315-323, 2010
139. Ashcroft BA, de Sonneville J, Yuana Y, Osanto S, Bertina R, Kuil ME, Oosterkamp TH: Determination of the size distribution of blood microparticles directly in plasma using atomic force microscopy and microfluidics. Biomed Microdevices 14: 641-649, 2012